Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.24B |
| 2 |
Microsoft
MSFT
|
+$433M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$419M |
| 4 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$332M |
| 5 |
RTX Corp
RTX
|
+$322M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AABA
Altaba Inc
AABA
|
+$267M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$181M |
| 3 |
BCR
CR Bard Inc.
BCR
|
+$134M |
| 4 |
IQVIA
IQV
|
+$134M |
| 5 |
LVLT
Level 3 Communications Inc
LVLT
|
+$121M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.07% |
| 2 | Financials | 5.97% |
| 3 | Healthcare | 5.8% |
| 4 | Consumer Discretionary | 5.2% |
| 5 | Communication Services | 4.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5501
CALL
Diodes
DIOD
$3.77B
| $63K | ﹤0.01% |
+2,200
| New | +$68.3K |
|
5502
CALL
Diamondback Energy
FANG
$55.9B
| $63K | ﹤0.01% |
+500
| New | +$54.2K |
|
5503
Future Fuel
FF
$215M
| $63K | ﹤0.01% |
4,470
+3,889
| +669% | +$57.9K |
|
5504
Farmers National Banc Corp
FMNB
$946M
| $63K | ﹤0.01% |
4,267
+3,282
| +333% | +$48.7K |
|
5505
Global Indemnity Group
GBLI
$402M
| $63K | ﹤0.01% |
1,513
+1,120
| +285% | +$47.7K |
|
5506
PUT
Louisiana-Pacific
LPX
$5.15B
| $63K | ﹤0.01% |
2,400
+2,000
| +500% | +$54.2K |
|
5507
NRC Health Common Stock
NRC
$432M
| $63K | ﹤0.01% |
1,679
+1,459
| +663% | +$51.8K |
|
5508
PUT
RenaissanceRe
RNR
$13.4B
| $63K | ﹤0.01% |
500
-1,200
| -71% | -$161K |
|
5509
Rapid7
RPD
$680M
| $63K | ﹤0.01% |
3,391
-956
| -22% | -$17.7K |
|
5510
Tandem Diabetes Care
TNDM
$1.38B
| $63K | ﹤0.01% |
+26,800
| New | +$84.2K |
|
|
KOL
5511
DELISTED
VanEck Vectors Coal ETF
KOL
| $63K | ﹤0.01% |
+395
| New | +$59.8K |
|
|
FBNK
5512
DELISTED
First Connecticut Bancorp, Inc
FBNK
| $63K | ﹤0.01% |
2,436
+1,809
| +289% | +$47.9K |
|
|
QADA
5513
DELISTED
QAD Inc.
QADA
| $63K | ﹤0.01% |
1,626
+1,388
| +583% | +$52.2K |
|
5514
Bassett Furniture
BSET
$169M
| $62K | ﹤0.01% |
1,652
+1,376
| +499% | +$52.8K |
|
5515
Sierra Bancorp
BSRR
$524M
| $62K | ﹤0.01% |
2,343
+1,754
| +298% | +$46.9K |
|
5516
Cato Corp
CATO
$69.3M
| $62K | ﹤0.01% |
3,845
-21,121
| -85% | -$306K |
|
5517
Digimarc Corp
DMRC
$161M
| $62K | ﹤0.01% |
1,718
+1,486
| +641% | +$54K |
|
5518
1-800-Flowers.com
FLWS
$269M
| $62K | ﹤0.01% |
5,808
+4,802
| +477% | +$47.9K |
|
5519
CALL
Heron Therapeutics
HRTX
$96.8M
| $62K | ﹤0.01% |
3,400
+1,900
| +127% | +$31K |
|
5520
CALL
Lindsay Corp
LNN
$1.15B
| $62K | ﹤0.01% |
700
-200
| -22% | -$18.2K |
|
|
MOFG
5521
DELISTED
MidWestOne Financial Group
MOFG
| $62K | ﹤0.01% |
1,850
+1,045
| +130% | +$36.9K |
|
5522
CALL
Novavax
NVAX
$1.22B
| $62K | ﹤0.01% |
+2,500
| New | +$61K |
|
5523
PUT
Enviri
NVRI
$651M
| $62K | ﹤0.01% |
3,300
-9,100
| -73% | -$175K |
|
5524
CALL
Plug Power
PLUG
$2.9B
| $62K | ﹤0.01% |
26,400
| – | – |
|
5525
CALL
Silicon Laboratories
SLAB
$7.19B
| $62K | ﹤0.01% |
700
+500
| +250% | +$44.9K |
|
Similar funds
Barclays's Q4 2017 Portfolio in Review
As of Q4 2017, Barclays held 7,416 positions worth $122B, up 26% from $97.1B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Barclays deployed $19.9B of net new capital in Q4 2017, opening 435 new positions and adding to 3,853 existing holdings. Its largest new stake was iShares US Home Construction ETF: 198,606 shares worth $8.68M.
By sector, the portfolio is most concentrated in Technology at 7.1% of assets, up from 6.2% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Altaba Inc, an estimated $267M trimmed.
- Barclays's largest Q4 2017 buy was iShares US Home Construction ETF: 198,606 shares worth $8.68M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.24B increase.
- Barclays's biggest Q4 2017 reduction was Altaba Inc, cutting an estimated $267M.
- Barclays fully exited CR Bard Inc. in Q4 2017, selling an estimated $134M.
- Barclays's ten largest holdings make up 24% of its $122B portfolio in Q4 2017.
- Barclays opened 435 new positions and closed 356 in Q4 2017.
- Barclays's portfolio value rose 26% quarter-over-quarter to $122B.
Based on Barclays's 13F filing for Q4 2017, filed 14 Feb 2018.